Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
7 September 2015 |
Main ID: |
NCT02534623 |
Date of registration:
|
15/08/2015 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Postoperative Quality of Recovery After Transurethral Resection of the Bladder
|
Scientific title:
|
Postoperative Quality of Recovery After Transurethral Resection of the Bladder: Spinal Versus General Anesthesia |
Date of first enrolment:
|
September 2015 |
Target sample size:
|
70 |
Recruitment status: |
Not yet recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT02534623 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Croatia
| | | | | | | |
Contacts
|
Name:
|
Nina Sulen, MD |
Address:
|
|
Telephone:
|
0038598738734 |
Email:
|
nina.sulen@zd.t-com.hr |
Affiliation:
|
|
|
Name:
|
Nina Sulen, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
General Hospital Zadar |
| |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Transurethral resection of the bladder
- Age 18 to 80 years
- ASA I-III
Exclusion Criteria:
- Contraindications for spinal anesthesia
- Chronic pain with use of opioids in the last week
- Psychiatric disorders
- Allergy to medications used in the study
Age minimum:
18 Years
Age maximum:
80 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Urinary Bladder Neoplasms
|
Postoperative Recovery
|
Transurethral Resection of the Bladder
|
Intervention(s)
|
Drug: propofol
|
Procedure: General anesthesia
|
Procedure: Spinal anesthesia
|
Drug: fentanyl
|
Drug: bupivacaine
|
Drug: sevoflurane
|
Primary Outcome(s)
|
Quality of Recovery 40 (QoR-40)
[Time Frame: 24 hours]
|
Secondary Outcome(s)
|
Patient satisfaction with anesthesia measured with numerical rating scale
[Time Frame: 24 hours]
|
Postoperative opioid consumption
[Time Frame: 24 hours]
|
Postoperative pain measured with visual analogue scale
[Time Frame: 1,6 and 24 hours]
|
Secondary ID(s)
|
GHZ trial 001
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|